Home  /  Resource Library  /  Lines of Therapy before Autologous Stem Cell Transplant (ASCT) and CAR-T Infusion Affect Outcomes in Aggressive Non-Hodgkin’s Lymphoma (NHL)

Lines of Therapy before Autologous Stem Cell Transplant (ASCT) and CAR-T Infusion Affect Outcomes in Aggressive Non-Hodgkin’s Lymphoma (NHL)

ASH 2020: Retrospective study examined the effect of previous lines of therapy on outcomes in patients with aggressive lymphomas treated with stem cell transplants and CAR T therapies.